Guillermo Tortolero-Luna to Survival Rate
                            
                            
                                This is a "connection" page, showing publications Guillermo Tortolero-Luna has written about Survival Rate.
                            
                            
                            
                                
                                    
                                            
    
        
        
        
            Connection Strength
            
                
            
            0.150
         
        
        
     
 
    
        
        - 
            Miller KD, Ortiz AP, Pinheiro PS, Bandi P, Minihan A, Fuchs HE, Martinez Tyson D, Tortolero-Luna G, Fedewa SA, Jemal AM, Siegel RL. Cancer statistics for the US Hispanic/Latino population, 2021. CA Cancer J Clin. 2021 11; 71(6):466-487.
            
            
                Score: 0.047
             
- 
            Miller KD, Goding Sauer A, Ortiz AP, Fedewa SA, Pinheiro PS, Tortolero-Luna G, Martinez-Tyson D, Jemal A, Siegel RL. Cancer Statistics for Hispanics/Latinos, 2018. CA Cancer J Clin. 2018 11; 68(6):425-445.
            
            
                Score: 0.038
             
- 
            Ortiz-Ortiz KJ, Tortolero-Luna G, R?os-Motta R, Veintid?s-Feli? A, Hunter-Mellado R, Torres-Cintr?n CR, Su?rez-Ramos T, Magno P. Use of adjuvant chemotherapy in patients with stage III colon cancer in Puerto Rico: A population-based study. PLoS One. 2018; 13(3):e0194415.
            
            
                Score: 0.037
             
- 
            Eggleston KS, Coker AL, Williams M, Tortolero-Luna G, Martin JB, Tortolero SR. Cervical cancer survival by socioeconomic status, race/ethnicity, and place of residence in Texas, 1995-2001. J Womens Health (Larchmt). 2006 Oct; 15(8):941-51.
            
            
                Score: 0.016
             
- 
            Deavers MT, Gershenson DM, Tortolero-Luna G, Malpica A, Lu KH, Silva EG. Micropapillary and cribriform patterns in ovarian serous tumors of low malignant potential: a study of 99 advanced stage cases. Am J Surg Pathol. 2002 Sep; 26(9):1129-41.
            
            
                Score: 0.012